0.5151
price up icon1.26%   0.0064
after-market Handel nachbörslich: .51 -0.0051 -0.99%
loading

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
109.16 4.173 0.791 0.771
Operating Expenses
0.93%
34.66
34.99 41.46 35.58 35.53
Benefits Costs and Expenses
65.14
- 38.47 32.02 31.96
Costs And Expenses
65.14
- 38.47 32.02 31.96
Operating Income/Loss
146.73%
-34.66
74.18 -37.28 -34.79 -34.76
Nonoperating Income/Loss
10.95%
2.123
2.384 2.987 3.555 3.57
Income/Loss From Continuing Operations Before Tax
142.50%
-32.54
76.56 -34.30 -31.23 -31.18
Income/Loss From Continuing Operations After Tax
142.50%
-32.54
76.56 -36.07 -31.23 -31.21
Net Income/Loss
142.50%
-32.54
76.56 -36.07 -31.23 -31.21
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.25%
86.24
86.02 2.2547 84.70 82.09
Diluted Average Shares
0.16%
86.24
86.10 2.2547 84.70 82.09
Basic Earnings Per Share
142.70%
-0.38
0.89 -0.43 -0.37 -0.38
Diluted Earnings Per Share
142.70%
-0.38
0.89 -0.43 -0.37 -0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):